Eden Research plc (EDEN) - Total Liabilities

Latest as of June 2025: GBX2.85 Million GBX ≈ $347.13 USD

Based on the latest financial reports, Eden Research plc (EDEN) has total liabilities worth GBX2.85 Million GBX (≈ $347.13 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Eden Research plc - Total Liabilities Trend (2004–2024)

This chart illustrates how Eden Research plc's total liabilities have evolved over time, based on quarterly financial data. See Eden Research plc (EDEN) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Eden Research plc Competitors by Total Liabilities

The table below lists competitors of Eden Research plc ranked by their total liabilities.

Company Country Total Liabilities
Rajvir Industries Limited
NSE:RAJVIR
India Rs1.13 Billion
Windar Photonics Plc
LSE:WPHO
UK GBX2.79 Million
Provexis plc
LSE:PXS
UK GBX230.95K
GETT Gold Inc
V:GETT
Canada CA$18.53 Million
SkinBioTherapeutics PLC
LSE:SBTX
UK GBX2.71 Million
International Zeolite Corp
V:IZ
Canada CA$2.88 Million
FOXO Technologies Inc.
NYSE MKT:FOXO
USA $31.96 Million
Carclo plc
LSE:CAR
UK GBX103.43 Million

Liability Composition Analysis (2004–2024)

This chart breaks down Eden Research plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Eden Research plc (EDEN) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.17 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.27 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.21 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Eden Research plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Eden Research plc (2004–2024)

The table below shows the annual total liabilities of Eden Research plc from 2004 to 2024.

Year Total Liabilities Change
2024-12-31 GBX3.57 Million
≈ $434.15
+17.03%
2023-12-31 GBX3.05 Million
≈ $370.97
+40.59%
2022-12-31 GBX2.17 Million
≈ $263.86
-1.32%
2021-12-31 GBX2.20 Million
≈ $267.39
+10.13%
2020-12-31 GBX2.00 Million
≈ $242.78
+31.53%
2019-12-31 GBX1.52 Million
≈ $184.59
+60.90%
2018-12-31 GBX942.87K
≈ $114.72
-54.49%
2017-12-31 GBX2.07 Million
≈ $252.10
+100.63%
2016-12-31 GBX1.03 Million
≈ $125.66
+37.23%
2015-12-31 GBX752.55K
≈ $91.56
+64.20%
2014-12-31 GBX458.30K
≈ $55.76
-46.34%
2013-12-31 GBX854.09K
≈ $103.92
-59.22%
2012-12-31 GBX2.09 Million
≈ $254.86
-27.97%
2011-12-31 GBX2.91 Million
≈ $353.82
-48.77%
2010-12-31 GBX5.68 Million
≈ $690.61
+37.80%
2009-12-31 GBX4.12 Million
≈ $501.16
+24.44%
2008-12-31 GBX3.31 Million
≈ $402.72
+19.83%
2007-12-31 GBX2.76 Million
≈ $336.09
-14.34%
2006-12-31 GBX3.22 Million
≈ $392.36
+45.99%
2005-12-31 GBX2.21 Million
≈ $268.76
+96.65%
2004-12-31 GBX1.12 Million
≈ $136.66
--

About Eden Research plc

LSE:EDEN UK Agricultural Inputs
Market Cap
$307.90K
GBX2.53 Billion GBX
Market Cap Rank
#30995 Global
#976 in UK
Share Price
GBX3.15
Change (1 day)
+0.00%
52-Week Range
GBX2.10 - GBX4.80
All Time High
GBX20.25
About

Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such a… Read more